Fig. 2

miR-302c-3p expression in endometrial carcinoma is low and suppresses the development of type I endometrial cancer cells in vitro. a MiR-302c-3p levels in endometrial cancer specimens (n = 35) versus normal endometrial tissues (n = 30) as determined by qRT-PCR. b Proliferation of miR-302c-3p-modified cells was examined by CCK-8 assay. c Invasion of miR-302c-3p-modified cells was examined by transwell cell invasion assays. d Cycle phases of miR-302c-3p-modified Ishikawa cells were examined by flow cytometry. e Fractions of apoptotic miR-302c-3p-modified Ishikawa cells were examined by flow cytometry. Data are the mean ± SD from independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001